Task: Answer the multiple-choice question.
Query: Which drug exhibits a 18.888% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CC(Sc1nnc(C(F)(F)F)n1C)C(=O)Nc1ccc(S(N)(=O)=O)cc1
b) CCCC[C@@H]1CNC(=S)N1CCC12CC3CC(CC(C3)C1)C2
Answer: b. CCCC[C@@H]1CNC(=S)N1CCC12CC3CC(CC(C3)C1)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC[C@@H]1CNC(=S)N1CCC12CC3CC(CC(C3)C1)C2
CCCC[C@@H]1CNC(=S)N1CCC12CC3CC(CC(C3)C1)C2
(5R)-1-[2-(1-adamantyl)ethyl]-5-butylimidazolidine-2-thione